ACT Biotech 
Welcome,         Profile    Billing    Logout  
 1 Product   0 Diseases   1 Product   0 Trials   2 News 
  • ||||||||||  EOC317 / EddingPharm
    Trial primary completion date, Metastases:  Study of EOC317 in Chinese Patients With Advanced Solid Tumors (clinicaltrials.gov) -  Sep 11, 2019   
    P1,  N=140, Recruiting, 
    Trial primary completion date: May 2019 --> Feb 2020